Sandra Leung compensation by year
BRISTOL MYERS SQUIBB Summary Compensation Table · all 9 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $919,945 | $947,436 | $975,860 | $1,008,635 | $1,068,271 | $1,100,196 | $1,133,074 | $1,147,819 | $1,150,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $2,883,253 | $3,047,660 | $3,290,794 | $3,172,998 | $3,330,729 | $3,434,134 | $3,441,053 | $3,345,168 | $3,959,204 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $1,214,632 | $1,493,890 | $1,680,159 | $1,586,482 | $1,642,236 | $1,298,162 | $1,238,952 | $1,123,091 | $1,613,335 |
| Pension and deferred compensation | $103,886 | $794,983 | $0 | $1,425,687 | $884,139 | $0 | $0 | $0 | $0 |
| All other | $320,085 | $259,448 | $296,370 | $322,655 | $318,570 | $329,092 | $291,748 | $307,403 | $289,251 |
| Total | $5,441,801 | $6,543,417 | $6,243,183 | $7,516,457 | $7,243,945 | $6,161,584 | $6,104,827 | $5,923,481 | $7,011,790 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BRISTOL MYERS SQUIBB CO DEF 14A filed March 26, 2025, accession 0000014272-25-000075, and prior-year filings. Open the filing on EDGAR.
How this page was built: the BRISTOL MYERS SQUIBB CO filed document, accession 0000014272-25-000075. Every figure is read from that document and cited to the page and table it appears in. Filed March 26, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 42,957 | $2,429,648 | — |
| RSU | 32,494 | $1,837,861 | — |
| RSU | 32,096 | $1,815,350 | — |
| RSU | 14,319 | $809,883 | — |
| RSU | 12,998 | $735,190 | — |
| RSU | 8,560 | $484,154 | — |
| RSU | 5,858 | $331,328 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in BRISTOL MYERS SQUIBB CO's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
BRISTOL MYERS SQUIBB’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Christopher Boerner | Board Chair and Chief Executive Officer | $18,787,618 |
| David Elkins | EVP and Chief Financial Officer | $8,707,571 |
| Samit Hirawat | Former EVP, Chief Medical Officer, Head of Development | $8,586,014 |
| Sandra Leung · this page | EVP and General Counsel | $7,011,790 |
| Karin Shanahan | EVP, Global Product Development & Supply | $6,566,581 |
The full BRISTOL MYERS SQUIBB compensation record
free company briefThis page is one person within BRISTOL MYERS SQUIBB's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BRISTOL MYERS SQUIBB proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BRISTOL MYERS SQUIBB's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.